Description: Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. Schrödinger was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in August 1990 and is headquartered in New York, NY.
Home Page: www.schrodinger.com
SDGR Technical Analysis
1540 Broadway
New York,
NY
10036
United States
Phone:
212 295 5800
Officers
| Name | Title |
|---|---|
| Dr. Ramy Farid Ph.D. | CEO, Pres & Director |
| Dr. Richard A. Friesner Ph.D. | Co-Founder, Scientific Advisory Chairman and Director |
| Mr. Kenneth Patrick Lorton | Exec. VP & CTO |
| Dr. Robert Lorne Abel Ph.D. | Exec. VP, Chief Computational Scientist and Head of Modeling R&D |
| Dr. Karen Akinsanya Ph.D. | Pres of R&D Therapeutics |
| Prof. William Goddard III | Co-Founder & Scientific Advisor |
| Dr. Geoffrey Craig Porges MBBS | Exec. VP & CFO |
| Mr. Shane Brauner | Exec. VP & Chief Information Officer |
| Ms. Jaren Irene Madden | Sr. VP of Investor Relations & Corp. Communications |
| Ms. Yvonne Tran Esq. | Exec. VP, Chief Legal Officer & Sec. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Technology |
| GIC Sub-Industry: | Health Care Technology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.5366 |
| Price-to-Sales TTM: | 8.321 |
| IPO Date: | 2020-02-06 |
| Fiscal Year End: | December |
| Full Time Employees: | 664 |